Send us a link
SARS-CoV-2 presents an unprecedented international challenge, but it will not be the last such threat. In this article, the authors argue that the world needs to be much better prepared to rapidly detect, define and defeat future pandemics.
As marchers in the United States and around the world filled the streets this past week to protest against police brutality and racial injustice, Black scientists grieved openly on social media, calling for action on racism in society and in science.
We invite researchers and data scientists focused on Coronavirus and COVID-19 vaccines and drugs, as well as clinical research, to freely access these solutions.
More than 140 scientists funded by the Chan Zuckerberg Initiative urged Mark Zuckerberg to enforce stricter policies around the spread of misinformation and incitements to violence.
The decision comes as new details emerge in the scandal that has ignited a firestorm of controversy in the scientific community.
It is easy to make excuses – the legacy of historic racism is so strong that there are not a lot of senior Black scientists to choose from, and those that have survived the gauntlet are in demand and overcommitted, and so on and so forth. But these excuses are lame.
Ignoring science's legacy of racism or a wider culture shaped by white supremacy doesn't make scientists "objective".
Restaurants get eulogies. Airlines get bailouts. Shakespeare gets kicked when he's down.
Acknowledge the history. Revise your work. Refuse to be complicit.
The now retracted paper halted hydroxychloroquine trials. Studies like this determine how people live or die tomorrow.
Despite the special calls for research into the novel coronavirus, researchers should all still concentrate on what they do best, writes Matthias Egger, President of the National Research Council of the SNSF.
STAT asked 11 experts in infectious disease, epidemiology, and pandemic preparedness how to avoid the mistakes of the coronavirus response this spring.
Humanities Research Infrastructure is critical social investment, and we could support it better if we understood it better.
Surgisphere, whose employees appear to include a sci-fi writer and adult content model, provided database behind Lancet and New England Journal of Medicine hydroxychloroquine studies.
Financial crises could spell trouble for science budgets but spending could surge in some countries. Series investigates science after the pandemic.
Providing open access to digitised collections has spurred creativity and research worldwide - so why are the UK's flagship museums so slow on the uptake?
Interdisciplinary collaborations between scientific researchers and artists can often be one dimensional, with artists simply illustrating scientific findings.
News coverage of scientific studies can be misleading. Here's how to tell the good from the bad.
With student enrolment projected to fall, some US and UK institutions have halted recruitment.
Virtual meetings are becoming the norm under COVID-19 and winning over many researchers: part 3 in a series on science after the pandemic.
It's not only about what's happening right now. Things need to change for good.
High-level politician suggests academy deserves retribution for publishing unwelcome COVID-19 estimates.
We are pleased to announce the next OASPA webinar which will explore recent steps to increase efficiency and speed in the publication of COVID-19 research (Wednesday 24th June 2020, 4.00 pm Central European Time).
Learned societies face many new challenges in the face of a pandemic.
The platform evaluates these journals’ peer-review procedures and invites journal editors to provide such information for inclusion in the database.
The push for rapid and open publishing could take off - although financial pressures lie ahead: part 4 in a series on science after the pandemic.
